Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain 
proliferation through EGFR

Henze, Anne-Theres; Garvalov, Boyan K.; Seidel, Sascha; Cuesta, Angel M.; Ritter, Mathias; Filatova, Alina; Foss, Franziska; Dopeso, Higinio; Essmann, Clara L.; Maxwell, Patrick H.; Reifenberger, Guido; Carmeliet, Peter; Acker-Palmer, Amparo; Acker, Till

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR

MPS-Authors

/persons/resource/persons38744

Acker-Palmer, Amparo
Neurovascular interface Group, Max Planck Institute for Brain Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Henze, A.-T., Garvalov, B. K., Seidel, S., Cuesta, A. M., Ritter, M., Filatova, A., et al. (2014). Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR. Nature Communications, 5, 5582.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002E-1C82-F

Abstract

There is no abstract available